Microbot Medical
MBOT
33 hedge funds and large institutions have $8.11M invested in Microbot Medical in 2013 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 3 closing their positions.
233% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 3
47% more capital invested
Capital invested by funds: $5.52M → $8.11M (+$2.59M)
27% more funds holding
Funds holding: 26 → 33 (+7)
14% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.11M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$997K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$184K |
| 4 |
BCM
Bourgeon Capital Management
Darien,
Connecticut
|
+$142K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$142K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OC
Oppenheimer & Co
New York
|
-$26K |
| 2 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
-$22K |
| 3 |
D.E. Shaw & Co
New York
|
-$21.2K |
| 4 |
U
UBS
Zurich,
Switzerland
|
-$8.47K |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
-$4.23K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
U
26
UBS
Zurich,
Switzerland
| $12K | -$8.47K | -4 | -40% |
|
27
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $12K | – | – | – |
|
28
Morgan Stanley
New York
| $11K | +$12.7K | +6 | New |
|
|
LTFS
29
Ladenburg Thalmann Financial Services
Miami,
Florida
| $3K | – | – | – |
|
30
Wells Fargo
San Francisco,
California
| $2K | – | – | – |
|
31
AllianceBernstein
Nashville,
Tennessee
| $1K | – | – | – |
|
|
VIA
32
Vantage Investment Advisors
State College,
Pennsylvania
| $1K | +$2.12K | +1 | New |
|
33
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $7 | +$8.47K | +4 | New |
|
|
OC
34
Oppenheimer & Co
New York
| – | -$26K | -10 | Closed |
|
|
RCM
35
Rotella Capital Management
Bellevue,
Washington
| – | -$22K | -8 | Closed |
|
|
RIA
36
Regal Investment Advisors
Kentwood,
Michigan
| – | -$4K | -1 | Closed |
|
MBOT Hedge Fund Activity: Q4 2013 in Review
33 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q4 2013, worth a combined $8.11M — up 47% from $5.52M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new MBOT positions and 3 closed out — a net gain of 7 holders — while 8 added to existing stakes and 7 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $1.11M. The largest seller was Oppenheimer & Co, exiting entirely with an estimated $26K sold.
- 33 institutional investors held Microbot Medical (MBOT) as of Q4 2013, up from 26 in Q3 2013.
- Funds reported $8.11M of Microbot Medical stock for Q4 2013, up 47% quarter-over-quarter.
- 10 funds opened new Microbot Medical positions in Q4 2013 and 3 closed out, a net change of +7 holders.
- The largest Microbot Medical buyer in Q4 2013 was Sabby Management, an estimated $1.11M added.
- The largest Microbot Medical seller in Q4 2013 was Oppenheimer & Co, an estimated $26K sold.
Based on aggregated 13F filings for Q4 2013.